Hadley Harbor Master Investors (Cayman) L.P.'s Net Worth

$483 Million

Estimate Recalculated Dec 3, 2025 07:32PM EST

Who is Hadley Harbor Master Investors (Cayman) L.P.

Hadley Harbor Master Investors (Cayman) L.P. has an estimated net worth of $483 Million. This is based on reported shares across multiple companies, which include Trade Desk, Inc., RHYTHM PHARMACEUTICALS, INC., PELOTON INTERACTIVE, INC., Invuity, Inc., PINTEREST, INC., ZUORA INC, NLIGHT, INC., Jounce Therapeutics, Inc., Nivalis Therapeutics, Inc., Voyager Therapeutics, Inc., CRISPR Therapeutics AG, Neon Therapeutics, Inc., Allena Pharmaceuticals, Inc., CytomX Therapeutics, Inc., Kala Pharmaceuticals, Inc., and FORESCOUT TECHNOLOGIES, INC.

SEC CIK

Hadley Harbor Master Investors (Cayman) L.P.'s CIK is 0001641080

Past Insider Trading and Trends

2017 was Hadley Harbor Master Investors (Cayman) L.P.'s most active year for acquiring shares with 6 total transactions. Hadley Harbor Master Investors (Cayman) L.P.'s most active month to acquire stocks was the month of September. 2017 was Hadley Harbor Master Investors (Cayman) L.P.'s most active year for disposing of shares, totalling 38 transactions. Hadley Harbor Master Investors (Cayman) L.P.'s most active month to dispose stocks was the month of February. 2019 saw Hadley Harbor Master Investors (Cayman) L.P. paying a total of $0.00 for 10,621,856 shares, this is the most they've acquired in one year. In 2020 Hadley Harbor Master Investors (Cayman) L.P. cashed out on 14,888,034 shares for a total of $126,911,647.61, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Trade Desk, Inc.

Investor
Updated May 01, 2017
Form 4
-4.26%
-76.64K
$37.56
-$2.88M
May 01, 2017
1.72M
Sale
Apr 27 - May 01
Form 4
-4.58%
-86.37K
$36.63
-$3.16M
Apr 27, 2017
1.80M
Sale
Apr 25 - Apr 26
Form 4
-3.98%
-78.23K
$36.40
-$2.85M
Apr 24, 2017
1.89M
Sale
Apr 20 - Apr 24
Form 4
-6.65%
-140.00K
$35.90
-$5.03M
Apr 19, 2017
1.96M
Sale
Apr 17 - Apr 19
Form 4
-4.10%
-90.00K
$37.45
-$3.37M
Apr 12, 2017
2.10M
Sale
Apr 10 - Apr 12
Form 4/A
-18.23%
-489.26K
$36.60
-$17.91M
Apr 12, 2017
2.19M
Sale
Mar 31
Form 4
-19.64%
-532.30K
$36.69
-$19.53M
Mar 31, 2017
2.18M
Sale
Mar 30 - Mar 31
Form 4
-5.62%
-161.40K
$37.48
-$6.05M
Mar 30, 2017
2.71M
Sale
Mar 28 - Mar 29
Form 4
-10.10%
-322.74K
$37.07
-$11.96M
Mar 28, 2017
2.87M
Sale
Mar 20 - Mar 27
Form 4
-66.67%
-6.39M
Sep 26, 2016
3.19M
Options
Sep 23
Form 3
Sep 20, 2016
Showing 11 results

RHYTHM PHARMACEUTICALS, INC.

Investor
Updated Oct 10, 2017
Form 4
-89.09%
-4.45M
Oct 10, 2017
545.26K
Options
Oct 10
Form 3
Oct 04, 2017
Showing 2 results

PELOTON INTERACTIVE, INC.

Investor
Updated Mar 26, 2020
Form 4
-16.28%
-965.00K
$24.70
-$23.83M
Mar 26, 2020
4.96M
Sale
Mar 24 - Mar 25
Form 4
-8.28%
-535.00K
$24.58
-$13.15M
Mar 24, 2020
5.93M
Sale
Mar 20 - Mar 23
Form 4
-21.91%
-1.81M
$26.13
-$47.38M
Mar 20, 2020
6.46M
Sale
Mar 18 - Mar 19
Form 4
-16.62%
-1.65M
$25.80
-$42.55M
Mar 19, 2020
8.28M
Sale
Feb 11 - Mar 17
Form 4
Sep 30, 2019
9.93M
Options
Sep 30
Form 3
Sep 25, 2019
Showing 6 results

Invuity, Inc.

Investor
Updated Jun 22, 2015
Form 4
4.70%
42.56K
Jun 22, 2015
948.80K
Options
Jun 18
Form 3
Jun 11, 2015
Showing 2 results

PINTEREST, INC.

Investor
Updated Apr 23, 2019
Form 4
Apr 23, 2019
696.50K
Options
Apr 23
Form 3
Apr 17, 2019
Showing 2 results

ZUORA INC

Investor
Updated Apr 11, 2018
Form 3
Apr 11, 2018
Showing 1 results

NLIGHT, INC.

Investor
Updated Apr 30, 2018
Form 4
Apr 30, 2018
3.34M
Options
Apr 30
Form 3
Apr 25, 2018
Showing 2 results

Jounce Therapeutics, Inc.

Investor
Updated Feb 01, 2017
Form 4
-72.90%
-1.94M
Feb 01, 2017
719.48K
Options
Feb 01
Form 3
Jan 26, 2017
Showing 2 results

Nivalis Therapeutics, Inc.

Investor
Updated Jun 23, 2015
Form 4
-65.39%
-688.27K
Jun 23, 2015
364.36K
Options
Jun 22
Form 3
Jun 16, 2015
Showing 2 results

Voyager Therapeutics, Inc.

Investor
Updated Nov 18, 2015
Form 4
-76.47%
-1.53M
Nov 18, 2015
470.59K
Options
Nov 16
Form 3
Nov 10, 2015
Showing 2 results

CRISPR Therapeutics AG

Investor
Updated Oct 24, 2016
Form 4
Oct 24, 2016
744.38K
Options
Oct 24
Form 3
Oct 18, 2016
Showing 2 results

Neon Therapeutics, Inc.

Investor
Updated Jun 29, 2018
Form 4
-80.00%
-2.66M
Jun 29, 2018
665.92K
Options
Jun 29
Form 3
Jun 26, 2018
Showing 2 results

Allena Pharmaceuticals, Inc.

Investor
Updated Nov 07, 2017
Form 4
-76.04%
-2.40M
Nov 07, 2017
757.68K
Options
Nov 06
Form 3
Nov 01, 2017
Showing 2 results

CytomX Therapeutics, Inc.

Investor
Updated Oct 14, 2015
Form 4
Oct 14, 2015
749.06K
Options
Oct 14
Form 3
Oct 07, 2015
Showing 2 results

Kala Pharmaceuticals, Inc.

Investor
Updated Jul 25, 2017
Form 4
-80.80%
-7.30M
Jul 25, 2017
1.74M
Options
Jul 25
Form 3
Jul 19, 2017
Showing 2 results

FORESCOUT TECHNOLOGIES, INC

Investor
Updated Oct 31, 2017
Form 4
17.41%
293.40K
Oct 31, 2017
1.98M
Options
Oct 31
Form 3
Oct 26, 2017
Showing 2 results